WELCOME TO The HEALTHCARE REPORT
Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...
Forbes | April 21, 2016
Scientists are super-excited about the way cheap, fast DNA sequencing technology is making it possible to gather vivid, detailed information about the microbiome. These are the trillions of bugs in our guts, and on our skin, that humans have co-existed with since the beginning. Drug companies, until fairly recently, haven’t been that interested, or at least haven’t seen clear ways the science can applied with new drugs. But that’s changing. Today, a little company in South San ...
| April 28, 2016
Drug companies Wyeth and Pfizer have agreed to pay $784.6 million to settle allegations that Wyeth did not provide the same drug discounts to Medicaid that it gave to private buyers, the U.S. Attorney's office announced Wednesday.
As part of the settlement, Wyeth and Pfizer do not deny the government's allegations. Pfizer, which is headquartered in New York City, bought Wyeth in 2009. The actions in question occurred before the acquisition....
dnaindia | May 16, 2016
Drug major Pfizer Inc on Monday said it will acquire biopharmaceutical firm Anacor Pharmaceuticals for around $5.2 billion in an all-cash deal. Pfizer and Anacor Pharmaceuticals have entered into a definitive merger agreement under which Pfizer will acquire Anacor for $99.25 per Anacor share, in cash, for a total transaction value, net of cash, of approximately $5.2 billion, Pfizer Inc said in a statement....
Healthcare Finance | December 19, 2018
Pharma giants Pfizer and GlaxoSmithKline are creating a joint venture consumer healthcare business. The Boards of Directors of both companies have unanimously approved the transaction under which Pfizer's consumer healthcare business will essentially roll into GlaxoSmithKline's existing consumer healthcare business. It will operate globally under the GSK Consumer Healthcare name. Pfizer will own less than 50 percent of the joint venture and GSK Consumer Healthcare expects to deconsolidat...
FUTURE OF HEALTHCARE
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
Put your news, events, company, and promotional content in front of thousands of your peers and potential customers.
Not a member yet? Not a problem, Sign Up
Sign up to contribute and publish your news, events, brand, and content with the
community for FREE